Novo Nordisk Seeks Injunction Against Eli Lilly in Dispute Over Weight-Loss Ads

Novo Nordisk is asking a U.S. court to preliminarily halt rival Eli Lilly from advertising weight-loss drugs, days after accusing the Indianapolis drugmaker of using deceptive ads.